CRISPR—Cas9 provide evidence that the technique is safe and feasible to use for treating human diseases.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
£17.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
£199.00 per year
only £3.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 578, 195 (2020)
doi: https://doi.org/10.1038/d41586-020-00339-3
Science (2020)
Download references
Job Title: Associate or Senior Editor, Nature Progress Brain Health [...]